Digital Health Global

MARCH 16, 2023

The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the life sciences. Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space.

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Digital Health Global

JUNE 20, 2023

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Lloyd Price

NOVEMBER 16, 2024

The new company aims to leverage its extensive data sets and technology to provide innovative solutions across various healthcare sectors, including life sciences, provider, imaging, health plan, employer, and government health and human services. Subscribe Today! In 2011, the Jeopardy!-winning Subscribe Today!

Drug Development 70

Drug Development healthcare technology Leadership Life Science 70

Healthcare IT Today

DECEMBER 6, 2024

In total, Aignostics has now raised over $55 million , reflecting investors’ confidence in its differentiated AI models and clear commercial strategy. About ATHOS With its heritage in healthcare and life sciences, ATHOS is a single-family office that supports entrepreneurs to positively impact health and well-being.

Life Science 64

Life Science Drug Development Health IT Healthcare IT 64

Healthcare IT Today

MAY 22, 2023

.” Prognos Health’s platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.

Life Science 69

Life Science Drug Development Health IT Healthcare IT 69

Digital Health Global

FEBRUARY 16, 2023

Their expertise in company building, capital formation, and drug development will be a tremendous resource to Avilar as the innovation leader in the new field of extracellular protein degradation.” Find out more: www.sanofiventures.com.

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Healthcare IT Today

NOVEMBER 14, 2022

Mountain Group Partners’ investment strategy has always focused squarely on supporting companies like AngelEye Heath that are developing transformational technologies that improve the lives of others,” said Byron Smith , Managing Director at Mountain Group Partners. About Mountain Group Partners. About SeedtoB.

Life Science 96

Life Science HIPAA Drug Development healthcare technology 96

Lloyd Price

FEBRUARY 18, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. link] HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Subscribe Today!

Pharmaceuticals 64

Pharmaceuticals healthcare technology Digital Health Remote care 64

Lloyd Price

DECEMBER 11, 2023

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”

Pharmaceuticals 64

Pharmaceuticals Digital Health Drug Development Life Science 64

Henry Kotula

MARCH 10, 2021

The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. However, life sciences companies seem to be struggling to select the best AI technologies, according to 73% of executives.

Life Science 41

Life Science Pharmaceuticals Drug Development EHR 41

Healthcare IT Today

JANUARY 9, 2023

Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. One of the core issues is that the industry has become single threaded in its sourcing strategy. Additionally, AI-powered platforms will be prioritized to accelerate the process of drug research and development.

Health IT 85

Health IT Pharmaceuticals Drug Development Life Science 85

Healthcare IT Today

JANUARY 17, 2024

and Director of Clinical Strategy at Particle Health I believe a huge place where generative AI will be able to gain traction in healthcare in 2024 is in developing operational workflows and clinical pathways for resource allocation to specific patient cohorts. Carolyn Ward, M.D.

Health IT 103

Health IT Mental health Interoperability Patient Experience 103